Preference List Defaults for High Blood Pressure

GM
SC
Overseen BySasha C Brietzke, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Geisinger Clinic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This study aims to evaluate whether modifying the EPIC preference list to display combination blood pressure (BP) medications at the top and/or adding "(PREFERRED)" to the beginning of the medication listing increases prescribing of these medications. Combination BP medications are aligned with value-based care guidelines and may improve patient adherence and reduce pill burden. Currently, these medications may be under-prescribed in part due to their low visibility in the EPIC prescribing interface.

Are You a Good Fit for This Trial?

Inclusion Criteria

I have a prescription for a medication that starts with names like amlodipine or losartan.
My treatment order was made during a clinic visit, call, or virtual meeting.
I am 18 years old or older.
See 2 more

What Are the Treatments Tested in This Trial?

Interventions

  • Revising preference list by adding "(PREFERRED)" to combination medication names

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Revised Preference ListExperimental Treatment1 Intervention
Group II: No Change to the Preference ListActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Geisinger Clinic

Lead Sponsor

Trials
159
Recruited
1,976,000+